Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00002091 · ClinicalTrials.gov registry record · NA

An Evaluation of Pentoxifylline in HIV-Positive Persons With Symptomatic HIV Infection and a Karnofsky Score > 40 Percent and < 100 Percent

A NA study of HIV Infections, sponsored by Community Research Initiative of New England.

Completed
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT00002091: Completed NA study of HIV Infections, sponsored by Community Research Initiative of New England.

NCT00002091 is a NA study of HIV Infections that has completed, run by Community Research Initiative of New England. The registered enrollment target is 60 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00002091, a NA study of HIV Infections, has completed, sponsored by Community Research Initiative of New England.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

PRIMARY: To determine whether pentoxifylline changes the self-reported measures of quality of life status, using measures of scores from double-blinded drug withdrawal and drug restart periods. SECONDARY: To measure the changes in monthly CD4 counts, fasting serum triglyceride levels, and weight; to assess the safety of pentoxifylline in HIV-infected persons.

Conditions Studied

HIV Infections

Interventions

  • DRUG Pentoxifylline

Study Locations (1)

Massachusetts

  • CRI of New England - Brookline

Trial Details

FieldValue
Enrollment Target 60 participants
Phase NA

Sponsor

Community Research Initiative of New England

9 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00002091

The ClinicalTrials.gov registry entry for NCT00002091 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (87% lower). The listed sponsor is Community Research Initiative of New England, which has 9 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which Pentoxifylline is the first listed.

NCT00002091 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00002091 about?

NCT00002091 is a clinical study titled "An Evaluation of Pentoxifylline in HIV-Positive Persons With Symptomatic HIV Infection and a Karnofsky Score > 40 Percent and < 100 Percent". PRIMARY: To determine whether pentoxifylline changes the self-reported measures of quality of life status, using measures of scores from double-blinded drug withdrawal and drug restart periods. SECONDARY: To measure the changes in monthly CD4 counts, fasting serum triglyceride levels, and weight; t...

What is the current status of trial NCT00002091?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants.

What conditions does trial NCT00002091 study?

This clinical trial studies the following conditions: HIV Infections.

What interventions are being tested in trial NCT00002091?

The interventions under investigation include: Pentoxifylline (DRUG).

Who is sponsoring clinical trial NCT00002091?

This trial is sponsored by Community Research Initiative of New England, which has 9 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00002091 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

HIV Infections

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.